NCT05688943

Brief Summary

This study compares general anesthesia and spinal anesthesia for vNOTE tubal sterilization. A direct comparison of these methods has not been done before for this surgical approach. Investigators will aim to compare the two methods to determine the differences in perioperative complications, postoperative pain, postoperative nausea and vomiting, and the time to get the patient ready for discharge from the recovery room.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Mar 2023Jul 2026

First Submitted

Initial submission to the registry

December 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

3.4 years

First QC Date

December 14, 2022

Last Update Submit

June 2, 2025

Conditions

Keywords

vNOTESTubal SterilizationRegional Anesthesialaparoscopy

Outcome Measures

Primary Outcomes (2)

  • Incidence of perioperative complications performing VNOTES tubal sterilization with Spinal Anesthesia

    This study seeks to explore the feasibility of performing vaginal natural orifice transluminal endoscopic surgery (VNOTES) tubal sterilization under small-dose spinal anesthesia compared to the gold standard, general anesthesia, in healthy patients and to analyze intraoperative complications.

    during surgery

  • Incidence of perioperative complications performing VNOTES tubal sterilization with Spinal Anesthesia

    This study seeks to explore the feasibility of performing vaginal natural orifice transluminal endoscopic surgery (VNOTES) tubal sterilization under small-dose spinal anesthesia compared to the gold standard, general anesthesia, in healthy patients and to analyze postoperative complications.

    up to 7 days after surgery

Secondary Outcomes (3)

  • Rate of post-operative pain between patients

    immediately after the surgery

  • Occurrence of postoperative nausea/vomiting

    immediately after the surgery

  • Compare time until PACU discharge-to-home readiness between patients

    immediately after the surgery

Study Arms (2)

General Anesthesia

ACTIVE COMPARATOR

This arm will receive general anesthesia for vNOTES surgery.

Procedure: General Anesthesia

Spinal Anesthesia

EXPERIMENTAL

This arm will receive spinal anesthesia for vNOTES surgery.

Procedure: Spinal Anesthesia

Interventions

Fentanyl (1µg/kg) and midazolam are administered intravenously prior to puncture. Using an aseptic technique, the subarachnoid space is punctured with a 25/27 gauge needle in the intervertebral space, and a standard dose of chloroprocaine 45-60mg is injected. Alternative spinal anesthetics include bupivacaine 6-15mg and mepivacaine 50-70mg. The participant is then placed in the supine position in 10-degree Trendelenburg until the lack of sensitivity is adequate at spinal level T4.

Also known as: Regional Anesthesia
Spinal Anesthesia

General anesthesia is a state of controlled unconsciousness. During a general anesthetic, medicines are used to send the participant to sleep making the participant unaware of surgery and so that the participant does not move or feel pain while the surgery is carried out. Induction of general anesthesia includes the use intravenous sedative-hypnotic agents such as propofol, etomidate, or ketamine, along with adjuvant agents such as fentanyl, lidocaine, or midazolam. A neuromuscular blocking agent such as succinylcholine or rocuronium is used to facilitate endotracheal intubation.

Also known as: Endotracheal intubation
General Anesthesia

Eligibility Criteria

Age21 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailscis-female or gender non-conforming person
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥21years old keeping in line with regulations posed by federally funded insurance programs
  • cis-female or gender non-conforming person with female reproductive organs
  • request for permanent sterilization
  • no prior hysterectomy or trachelectomy
  • undergoing tubal sterilization only or salpingo-oophorectomy only for cancer risk reduction due to genetic pre-disposition
  • non-emergent/scheduled outpatient procedure
  • non-pregnant, ≥6 weeks postpartum
  • American Society of Anesthesia (ASA) physical status classification I or II
  • All subjects must be determined to be appropriate candidates for VNOTES by the surgeon based on the review of medical and surgical history
  • Those undergoing additional procedures such as insertion or removal of a long-acting reversible contraceptive (Intrauterine device or subdermal implant) may be included.

You may not qualify if:

  • Ectopic pregnancy, ovarian torsion, or adnexal mass requiring urgent or emergent treatment;
  • Trans-masculine person considering surgical masculinization due to additional surgeries involved;
  • Undergoing adnexal surgery for suspected or confirmed malignancy;
  • History of endometriosis, or other inflammatory diseases that have been determined to add to the complexity and increase the risk of injury with vaginal surgery;
  • prior genital surgery or congenital abnormality that would prevent vaginal access;
  • prior spinal surgery or severe scoliosis that would hinder placement and effective functioning of neuraxial anesthetics;
  • uncorrected thrombocytopenia or coagulopathy;
  • ASA physical status classification ≥III.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Interventions

Anesthesia, SpinalAnesthesia, ConductionAnesthesia, GeneralIntubation, Intratracheal

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaAirway ManagementTherapeuticsIntubationInvestigative Techniques

Study Officials

  • Meredith K Gray, MD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This a a randomized control trail that will have 2 groups. One will be the control group and will receive the standard of care, general anesthesia. The other group will be the experimental group which will receive spinal anesthesia in place in general anesthesia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Obstetrics & Gynecology

Study Record Dates

First Submitted

December 14, 2022

First Posted

January 18, 2023

Study Start

March 1, 2023

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

July 15, 2026

Last Updated

June 5, 2025

Record last verified: 2025-06

Locations